Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAST Vaccine Combined with Radiotherapy in Advanced or Recurrent Tumors
NCT06756295Phase 1Not yet recruiting
- Start
- Mar 2025
- Primary completion
- Mar 2028
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
01
Overview
Phase 1, randomised, open-label trial of FAST vaccine in breast cancer, colorectal cancer (CRC), melanoma and 1 more (2 arms). Primary endpoint: Safety Evaluation at 1 month. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
FAST vaccine
03
Conditions
breast cancercolorectal cancer (CRC)melanomalung cancer
Beyond the preview
Go deeper on NCT06756295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06756295.